Multiple behavioral anomalies in GluR2 mutant mice exhibiting enhanced LTP.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 9754875)

Published in Behav Brain Res on September 01, 1998

Authors

R Gerlai1, J T Henderson, J C Roder, Z Jia

Author Affiliations

1: Samuel Lunenfeld Research Institute, Mount Sinai Hospital, Toronto, Ont., Canada. gerlai@gene.com

Articles citing this

Synaptic AMPA receptor plasticity and behavior. Neuron (2009) 5.58

Impaired GABAergic transmission and altered hippocampal synaptic plasticity in collybistin-deficient mice. EMBO J (2007) 1.49

Mechanisms underlying autoimmune synaptic encephalitis leading to disorders of memory, behavior and cognition: insights from molecular, cellular and synaptic studies. Eur J Neurosci (2010) 1.13

Cellular plasticity induced by anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies. Ann Neurol (2015) 1.13

Effects of deletion of gria1 or gria2 genes encoding glutamatergic AMPA-receptor subunits on place preference conditioning in mice. Psychopharmacology (Berl) (2004) 1.11

A role for calcium-permeable AMPA receptors in synaptic plasticity and learning. PLoS One (2010) 1.11

Chronic enhancement of CREB activity in the hippocampus interferes with the retrieval of spatial information. Learn Mem (2009) 1.04

The roles of the dystrophin-associated glycoprotein complex at the synapse. Mol Neurobiol (2009) 0.96

Synthetic microRNA-mediated downregulation of Nogo-A in transgenic rats reveals its role as regulator of synaptic plasticity and cognitive function. Proc Natl Acad Sci U S A (2013) 0.90

Genes and signaling pathways involved in memory enhancement in mutant mice. Mol Brain (2014) 0.84

Tau pathology induces loss of GABAergic interneurons leading to altered synaptic plasticity and behavioral impairments. Acta Neuropathol Commun (2013) 0.83

Defective place cell activity in nociceptin receptor knockout mice with elevated NMDA receptor-dependent long-term potentiation. J Physiol (2005) 0.82

Promoter-Specific Effects of DREADD Modulation on Hippocampal Synaptic Plasticity and Memory Formation. J Neurosci (2016) 0.81

Test- and behavior-specific genetic factors affect WKY hypoactivity in tests of emotionality. Behav Brain Res (2006) 0.81

Specificity protein 4 (Sp4) regulates the transcription of AMPA receptor subunit GluA2 (Gria2). Biochim Biophys Acta (2014) 0.81

Evaluating the translational potential of progesterone treatment following transient cerebral ischaemia in male mice. BMC Neurosci (2014) 0.79

Impaired memory and reduced sensitivity to the circadian period lengthening effects of methamphetamine in mice selected for high methamphetamine consumption. Behav Brain Res (2013) 0.79

Motor Learning Requires Purkinje Cell Synaptic Potentiation through Activation of AMPA-Receptor Subunit GluA3. Neuron (2017) 0.78

Stargazer--a mouse to seize! Epilepsy Curr (2005) 0.78

Nuclear respiratory factor 2 regulates the transcription of AMPA receptor subunit GluA2 (Gria2). Biochim Biophys Acta (2014) 0.77

Signalling through AMPA receptors on oligodendrocyte precursors promotes myelination by enhancing oligodendrocyte survival. Elife (2017) 0.75

Articles by these authors

Derivation of completely cell culture-derived mice from early-passage embryonic stem cells. Proc Natl Acad Sci U S A (1993) 20.33

Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell (1998) 5.92

Characterization of two classes of small molecule inhibitors of Arp2/3 complex. Nature (2009) 3.83

A YAC mouse model for Huntington's disease with full-length mutant huntingtin, cytoplasmic toxicity, and selective striatal neurodegeneration. Neuron (1999) 3.50

Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell (1996) 3.19

A three-dimensional MRI atlas of the mouse brain with estimates of the average and variability. Cereb Cortex (2004) 2.90

Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J Neurosci (1997) 2.89

Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1. J Neurophysiol (2001) 2.76

Beta-helix structure and ice-binding properties of a hyperactive antifreeze protein from an insect. Nature (2000) 2.51

Mimicry of ice structure by surface hydroxyls and water of a beta-helix antifreeze protein. Nature (2000) 2.45

Target-effector interaction in the natural killer (NK) cell system. II. The isolation of NK cells and studies on the mechanism of killing. J Immunol (1978) 2.29

CAKbeta/Pyk2 kinase is a signaling link for induction of long-term potentiation in CA1 hippocampus. Neuron (2001) 2.22

The beige mutation in the mouse. I. A stem cell predetermined impairment in natural killer cell function. J Immunol (1979) 2.11

The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron (2001) 2.02

The beige mutation in the mouse. II. Selectivity of the natural killer (NK) cell defect. J Immunol (1979) 2.02

Src activation in the induction of long-term potentiation in CA1 hippocampal neurons. Science (1998) 1.81

A new immunodeficiency disorder in humans involving NK cells. Nature (1980) 1.78

Recognition of myelin-associated glycoprotein by the monoclonal antibody HNK-1. Nature (1984) 1.77

Regulation of T cell activation, anxiety, and male aggression by RGS2. Proc Natl Acad Sci U S A (2000) 1.73

Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines. Proc Natl Acad Sci U S A (1982) 1.73

Unsafe abortion after legalisation in Nepal: a cross-sectional study of women presenting to hospitals. BJOG (2013) 1.73

Target-effector interaction in the natural killer cell system: isolation of target structures. Proc Natl Acad Sci U S A (1979) 1.71

Crystal structure of calpain reveals the structural basis for Ca(2+)-dependent protease activity and a novel mode of enzyme activation. EMBO J (1999) 1.70

Target--effector interaction in the natural killer cell system. I. Covariance and genetic control of cytolytic and target-cell-binding subpopulations in the mouse. Scand J Immunol (1978) 1.70

Target-effector interaction in the human and murine natural killer system: specificity and xenogeneic reactivity of the solubilized natural killer-target structure complex and its loss in a somatic cell hybrid. J Exp Med (1979) 1.63

Downregulation of Wnt2 and beta-catenin by siRNA suppresses malignant glioma cell growth. Cancer Gene Ther (2008) 1.61

Protein tyrosine phosphatases take off. Nat Struct Biol (1995) 1.51

Blockade of glutamate receptors and barbiturate anesthesia: increased sensitivity to pentobarbital-induced anesthesia despite reduced inhibition of AMPA receptors in GluR2 null mutant mice. Anesthesiology (1999) 1.51

3,5-Bis-benzylidene-4-piperidones and related compounds with high activity towards P388 leukemia cells. Drug Des Deliv (1990) 1.51

Requirements for the establishment of high-titered human monoclonal antibodies against tetanus toxoid using the Epstein-Barr virus technique. J Immunol (1981) 1.45

Low natural in vivo resistance to syngeneic leukaemias in natural killer-deficient mice. Nature (1980) 1.42

Functional expression of the Schizosaccharomyces pombe Na+/H+ antiporter gene, sod2, in Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (1996) 1.38

Natural killer cells. Prog Allergy (1981) 1.38

Reduced fear and aggression and altered serotonin metabolism in Gtf2ird1-targeted mice. Genes Brain Behav (2007) 1.37

High level functional engraftment of severe combined immunodeficient mice with human peripheral blood lymphocytes following pretreatment with radiation and anti-asialo GM1. J Immunol Methods (1994) 1.32

Evidence that many of the DISC1 isoforms in C57BL/6J mice are also expressed in 129S6/SvEv mice. Mol Psychiatry (2007) 1.32

Neuronal defects and posterior pituitary hypoplasia in mice lacking the receptor tyrosine phosphatase PTPsigma. Nat Genet (1999) 1.31

Blockade of AMPA receptors and volatile anesthetics: reduced anesthetic requirements in GluR2 null mutant mice for loss of the righting reflex and antinociception but not minimum alveolar concentration. Anesthesiology (2001) 1.27

Repair of spontaneously deamidated HPr phosphocarrier protein catalyzed by the L-isoaspartate-(D-aspartate) O-methyltransferase. J Biol Chem (1994) 1.26

Recombinant myelin-associated glycoprotein confers neural adhesion and neurite outgrowth function. Neuron (1989) 1.25

Chemiluminescence response of human natural killer cells. I. The relationship between target cell binding, chemiluminescence, and cytolysis. J Exp Med (1982) 1.23

Oxygen intermediates are triggered early in the cytolytic pathway of human NK cells. Nature (1982) 1.22

Target-effector interaction in the natural killer cell system. IV. Modulation by cyclic nucleotides. J Immunol (1979) 1.20

An expanded population of natural killer cells in mice with severe combined immunodeficiency (SCID) lack rearrangement and expression of T cell receptor genes. J Exp Med (1986) 1.19

Organization of a repetitive human 1.8 kb KpnI sequence localized in the heterochromatin of chromosome 15. Chromosoma (1985) 1.19

Modulation of NMDA receptors by pituitary adenylate cyclase activating peptide in CA1 neurons requires G alpha q, protein kinase C, and activation of Src. J Neurosci (2005) 1.18

Development of a high resolution three-dimensional surgical atlas of the murine head for strains 129S1/SvImJ and C57Bl/6J using magnetic resonance imaging and micro-computed tomography. Neuroscience (2006) 1.17

Ssp1 promotes actin depolymerization and is involved in stress response and new end take-off control in fission yeast. Mol Biol Cell (1999) 1.17

Use-dependent AMPA receptor block in mice lacking GluR2 suggests postsynaptic site for LTP expression. Nat Neurosci (1998) 1.15

Target-effector cell interaction in the natural killer cell system. V. Energy requirements, membrane integrity, and the possible involvement of lysosomal enzymes. Immunology (1980) 1.15

Studies of human natural killer cells. II. Analysis at the single cell level. J Immunol (1982) 1.13

A functional comparison of tumor cell killing by activated macrophages and natural killer cells. Eur J Immunol (1979) 1.12

Binding specificities of the sialoadhesin family of I-type lectins. Sialic acid linkage and substructure requirements for binding of myelin-associated glycoprotein, Schwann cell myelin protein, and sialoadhesin. J Biol Chem (1997) 1.12

The biology of the human natural killer cell. J Clin Immunol (1982) 1.11

Inducible cellular transformation by a metallothionein-ras hybrid oncogene leads to natural killer cell susceptibility. Nature (1986) 1.11

Impaired cerebellar synaptic plasticity and motor performance in mice lacking the mGluR4 subtype of metabotropic glutamate receptor. J Neurosci (1996) 1.11

Crystal structures of Escherichia coli phytase and its complex with phytate. Nat Struct Biol (2000) 1.08

Suppressor cells in immunosenescence. Fed Proc (1978) 1.08

AIDS and the i.v. drug user: the local context in prevention efforts. Med Anthropol (1992) 1.07

Intra-rectal injection of tumour cells: a novel animal model of rectal cancer. Surg Oncol (1992) 1.06

Efficient antitumor immunity derived from maturation of dendritic cells that had phagocytosed apoptotic/necrotic tumor cells. Int J Cancer (2001) 1.05

Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma. Hybridoma (1982) 1.04

Enhanced dopamine function in DISC1-L100P mutant mice: implications for schizophrenia. Genes Brain Behav (2010) 1.04

Tumor necrosis factor receptor-associated factor 6 (TRAF6) deficiency results in exencephaly and is required for apoptosis within the developing CNS. J Neurosci (2000) 1.03

The mammalian ShcB and ShcC phosphotyrosine docking proteins function in the maturation of sensory and sympathetic neurons. Neuron (2000) 1.03

Src potentiation of NMDA receptors in hippocampal and spinal neurons is not mediated by reducing zinc inhibition. J Neurosci (1999) 1.03

Quantitative and qualitative analysis of type III antifreeze protein structure and function. J Biol Chem (1999) 1.01

Establishment of a human large cell lung tumor line (QU-DB) with metastatic properties in athymic mice. Cancer (1986) 1.01

The Lurcher mutation of an alpha-amino-3-hydroxy-5-methyl- 4-isoxazolepropionic acid receptor subunit enhances potency of glutamate and converts an antagonist to an agonist. J Biol Chem (2000) 1.01

Gender and patient satisfaction in managed care plans: analysis of the 1999 HEDIS/CAHPS 2.0H Adult Survey. Womens Health Issues (2001) 1.01

The EBV-hybridoma technique. Methods Enzymol (1986) 1.00

Natural killer (HNK-1+) cells in Chediak-Higashi patients are present in normal numbers but are abnormal in function and morphology. J Clin Invest (1982) 1.00

Chemical cross-linking of bovine retinal transducin and cGMP phosphodiesterase. J Biol Chem (1988) 1.00

Decreased neuronal Na+, K+ -ATPase activity in Atp1a3 heterozygous mice increases susceptibility to depression-like endophenotypes by chronic variable stress. Genes Brain Behav (2011) 1.00

Smad7 gene transfer inhibits peritoneal fibrosis. Kidney Int (2007) 0.99

Myelin-associated glycoprotein, a cell adhesion molecule of oligodendrocytes, is phosphorylated in brain. Mol Cell Biol (1988) 0.99

Spatial learning in transgenic mice expressing human presenilin 1 (PS1) transgenes. Neurobiol Aging (2000) 0.98

Dissociation and aggregation of calpain in the presence of calcium. J Biol Chem (2001) 0.98

Gender and patient satisfaction with primary care: tuning in to women in quality measurement. J Womens Health Gend Based Med (2000) 0.98

T cell activation and cellular cooperation in autoimmune NZB/NZW F hybrid mice. J Immunol (1975) 0.98

Differential splicing of MAG transcripts during CNS and PNS development. Brain Res (1988) 0.98

Why does Juan García have a drinking problem? The perspective of critical medical anthropology. Med Anthropol (1992) 0.97

Mechanism and structural requirements for transformation of substrates by the (S)-adenosyl-L-methionine:delta 24(25)-sterol methyl transferase from Saccharomyces cerevisiae. Biochim Biophys Acta (1996) 0.97

Topology of OxlT, the oxalate transporter of Oxalobacter formigenes, determined by site-directed fluorescence labeling. J Bacteriol (2001) 0.97

Induction of NMDA receptor-dependent long-term depression in visual cortex does not require metabotropic glutamate receptors. J Neurophysiol (1999) 0.96

Myelin-associated glycoprotein binding to gangliosides. Structural specificity and functional implications. Ann N Y Acad Sci (1998) 0.95

Regulation of the immune response in autoimmune NZB/NZW F1 mice. I. The spontaneous generation of splenic suppressor cells. Cell Immunol (1977) 0.95

Systemic administration of ciliary neurotrophic factor induces cachexia in rodents. J Clin Invest (1994) 0.95

The effects of steric mutations on the structure of type III antifreeze protein and its interaction with ice. J Mol Biol (1998) 0.95

Forward genetic screen of mouse reveals dominant missense mutation in the P/Q-type voltage-dependent calcium channel, CACNA1A. Genes Brain Behav (2007) 0.94

Reducing maternal mortality due to elective abortion: Potential impact of misoprostol in low-resource settings. Int J Gynaecol Obstet (2007) 0.94

Smoking and risk factors in deep vein thrombosis. Thromb Haemost (1978) 0.94

Affinity selection from peptide libraries to determine substrate specificity of protein tyrosine phosphatases. Anal Biochem (1998) 0.94

Class I (H-2Kb) gene transfection reduces susceptibility of YAC-1 lymphoma targets to natural killer cells. Eur J Immunol (1990) 0.94

In vitro NK-activity and in vivo resistance to leukemia: studies of beige, beige//nude and wild-type hosts on C57BL background. Int J Cancer (1980) 0.93

Calpain mutants with increased Ca2+ sensitivity and implications for the role of the C(2)-like domain. J Biol Chem (2000) 0.92